Co-Delivery of Hesperetin and Cisplatin via Hyaluronic Acid-Modified Liposome for Targeted Inhibition of Aggression and Metastasis of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Co-Delivery of Hesperetin and Cisplatin via Hyaluronic Acid-Modified Liposome for Targeted Inhibition of Aggression and Metastasis of Triple-Negative Breast Cancer

Published:2023-07-11 Issue:29 Volume:15 Page:34360-34377
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Wang Xiangpeng¹,Song Yurong¹,Yu Liuchunyang¹,Xue Xiaoxia¹,Pang Mingshi¹,Li Yang¹,Luo Xinyi¹,Hua Zhenglai¹,Lu Cheng²,Lu Aiping³,Liu Yuanyan¹^ORCID

Affiliation:

1. School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China

2. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

3. School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong

Funder

Beijing University of Chinese Medicine

Natural Science Foundation of Beijing Municipality

National Major Science and Technology Projects of China

Ministry of Finance

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.3c03233

Reference69 articles.

1. Triple-negative breast cancer molecular subtyping and treatment progress

2. Predictive Factors and Patterns of Recurrence in Patients with Triple Negative Breast Cancer

3. Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer

4. Metabolic reprogramming and cancer progression

5. E-cadherin is required for metastasis in multiple models of breast cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive review of Hesperetin: Advancements in pharmacokinetics, pharmacological effects, and novel formulations;Fitoterapia;2024-12

2. Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets;MedComm;2024-08

3. Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics;Journal of Controlled Release;2024-07

4. Recent Progress of Multifunctional Molecular Probes for Triple-Negative Breast Cancer Theranostics;Pharmaceutics;2024-06-14

5. Co-assembly of cisplatin and dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects;International Journal of Biological Macromolecules;2024-06